Earlier this month, Medtech Insight reported a dispute between the Food and Drug Administration and Philips over the number of injuries and deaths linked to a recall of the company’s breathing machines.
The question centered around a March recall of 100,000 Philips BiPAP A30, BiPAP A40, BiPAP V30, and OmniLab Advanced Plus...






